Scott D Sandell - Net Worth and Insider Trading
Scott D Sandell Net Worth
The estimated net worth of Scott D Sandell is at least $3.5 Billion dollars as of 2024-04-27. Scott D Sandell is the 10% Owner of Tesaro Inc and owns about 10,420,645 shares of Tesaro Inc (TSRO) stock worth over $781 Million. Scott D Sandell is the Director, 10% Owner of iShares Indl/Office Real Estate Capped and owns about 13,605,419 shares of iShares Indl/Office Real Estate Capped (FNIO) stock worth over $434 Million. Scott D Sandell is also the Director of Robinhood Markets Inc and owns about 23,850,644 shares of Robinhood Markets Inc (HOOD) stock worth over $426 Million. Besides these, Scott D Sandell also holds Arcellx Inc (ACLX) , Supernus Pharmaceuticals Inc (SUPN) , Rhythm Pharmaceuticals Inc (RYTM) , Ra Pharmaceuticals Inc (RARX) , Echo Global Logistics Inc (ECHO) , Adaptimmune Therapeutics PLC (ADAP) , Savara Inc (SVRA) , Mirum Pharmaceuticals Inc (MIRM) , Ardelyx Inc (ARDX) , Korro Bio Inc (KRRO) , Boingo Wireless Inc (WIFI) , AVEO Pharmaceuticals Inc (AVEO) , Akouos Inc (AKUS) , Groupon Inc (GRPN) , Trevi Therapeutics Inc (TRVI) , Liquidia Corp (LQDA) , Mersana Therapeutics Inc (MRSN) , Cloudflare Inc (NET) , InnerWorkings Inc (INWK) , Millennial Media Inc (MM) , Bloom Energy Corp (BE) , Inozyme Pharma Inc (INZY) , Tableau Software Inc (DATA) , Epizyme Inc (EPZM) , GlycoMimetics Inc (GLYC) , Marker Therapeutics Inc (MRKR) , Surface Oncology Inc (SURF) , Regulus Therapeutics Inc (RGLS) , Workday Inc (WDAY) , Eargo Inc (EAR) , Catalyst Biosciences Inc (CBIO) , Dermira Inc (DERM) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , Clovis Oncology Inc (CLVSQ) , TRACON Pharmaceuticals Inc (TCON) , Metacrine Inc (MTCR) , Novation Companies Inc (NOVCQ) , ARCA biopharma Inc (ABIO) , Genocea Biosciences Inc (GNCAQ) , Appian Corp (APPN) . Details can be seen in Scott D Sandell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Scott D Sandell has not made any transactions after 2024-04-22 and currently still holds the listed stock(s).
Transaction Summary of Scott D Sandell
Scott D Sandell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott D Sandell owns 108 companies in total, including Eargo Inc (EAR) , Metacrine Inc (MTCR) , and Mersana Therapeutics Inc (MRSN) among others .
Click here to see the complete history of Scott D Sandell’s form 4 insider trades.
Insider Ownership Summary of Scott D Sandell
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
EAR | Eargo Inc | 2020-10-20 | 10 percent owner |
MTCR | Metacrine Inc | 2021-12-22 | 10 percent owner |
MRSN | Mersana Therapeutics Inc | 2020-04-14 | 10 percent owner |
NET | Cloudflare Inc | 2023-11-20 | director & 10 percent owner |
SPT | Sprout Social Inc | 2019-12-12 | 10 percent owner |
BE | Bloom Energy Corp | 2018-07-27 | director & 10 percent owner |
INZY | Inozyme Pharma Inc | 2020-07-28 | 10 percent owner |
GNCAQ | Genocea Biosciences Inc | 2022-05-25 | 10 percent owner |
ANNX | Annexon Inc | 2020-07-23 | 10 percent owner |
NKTX | Nkarta Inc | 2020-07-09 | 10 percent owner |
ARDX | Ardelyx Inc | 2021-12-15 | 10 percent owner |
AKUS | Akouos Inc | 2020-06-30 | 10 percent owner |
AVEO | AVEO Pharmaceuticals Inc | 2020-06-19 | 10 percent owner |
SURF | Surface Oncology Inc | 2018-04-23 | 10 percent owner |
SENS | Senseonics Holdings Inc | 2016-03-17 | 10 percent owner |
TRVI | Trevi Therapeutics Inc | 2022-04-11 | 10 percent owner |
RARX | Ra Pharmaceuticals Inc | 2020-04-02 | 10 percent owner |
IMRA | Imara Inc | 2020-03-11 | 10 percent owner |
CSBR | Champions Oncology Inc | 2015-03-11 | 10 percent owner |
CSPR | Casper Sleep Inc | 2020-02-06 | 10 percent owner |
BDTX | Black Diamond Therapeutics Inc | 2020-01-29 | 10 percent owner |
ADAP | Adaptimmune Therapeutics PLC | 2020-01-24 | 10 percent owner |
RGLS | Regulus Therapeutics Inc | 2020-12-04 | 10 percent owner |
PTI | Proteostasis Therapeutics Inc | 2019-11-26 | 10 percent owner |
GRTX | Galera Therapeutics Inc | 2019-11-06 | 10 percent owner |
OYST | Oyster Point Pharma Inc | 2019-10-30 | 10 percent owner |
MIRM | Mirum Pharmaceuticals Inc | 2019-07-22 | 10 percent owner |
NITE | Nightstar Therapeutics PLC | 2019-06-07 | 10 percent owner |
TSRO | Tesaro Inc | 2019-01-22 | 10 percent owner |
MLND | Millendo Therapeutics Inc | 2018-12-07 | 10 percent owner |
PHASQ | PhaseBio Pharmaceuticals Inc | 2018-10-17 | 10 percent owner |
MRKR | Marker Therapeutics Inc | 2021-03-16 | 10 percent owner |
ESTC | Elastic NV | 2018-10-04 | 10 percent owner |
LQDA | Liquidia Corp | 2018-07-30 | 10 percent owner |
GLYC | GlycoMimetics Inc | 2023-01-26 | 10 percent owner |
MULE | MuleSoft Inc | 2018-05-01 | 10 percent owner |
TCON | TRACON Pharmaceuticals Inc | 2018-03-27 | 10 percent owner |
CASC | Cascadian Therapeutics Inc | 2018-03-09 | 10 percent owner |
ABIO | ARCA biopharma Inc | 2018-02-26 | 10 percent owner |
TNTRQ | Tintri Inc | 2018-02-26 | 10 percent owner |
APPN | Appian Corp | 2017-11-27 | 10 percent owner |
SYBX | Synlogic Inc | 2015-09-30 | 10 percent owner |
SBBP | Strongbridge Biopharma PLC | 2018-01-01 | 10 percent owner |
XFOR | X4 Pharmaceuticals Inc | 2017-11-20 | 10 percent owner |
CRCM | Care.com Inc | 2017-11-06 | 10 percent owner |
RYTM | Rhythm Pharmaceuticals Inc | 2017-10-10 | 10 percent owner |
ZSANQ | Zosano Pharma Corp | 2015-01-26 | 10 percent owner |
AKAOQ | Achaogen Inc | 2016-12-19 | 10 percent owner |
ROKA | Sorrento Tech Inc | 2016-09-21 | 10 percent owner |
ILIU | Interleukin Genetics Inc | 2016-07-29 | 10 percent owner |
OPWR | Opower Inc | 2016-06-14 | 10 percent owner |
TRIV | TriVascular Technologies Inc | 2016-02-03 | 10 percent owner |
EPZM | Epizyme Inc | 2016-01-12 | 10 percent owner |
SUPN | Supernus Pharmaceuticals Inc | 2015-06-17 | 10 percent owner |
AVTX | Avalo Therapeutics Inc | 2015-10-14 | 10 percent owner |
VTAE | Vitae Pharmaceuticals Inc | 2015-07-01 | 10 percent owner |
BOX | Box Inc | 2015-01-22 | 10 percent owner |
WIFI | Boingo Wireless Inc | 2014-12-19 | 10 percent owner |
TRVN | Trevena Inc | 2014-01-30 | 10 percent owner |
DATA | Tableau Software Inc | 2014-12-05 | director |
CVT | Cvent Inc | 2014-11-25 | 10 percent owner |
DERM | Dermira Inc | 2014-10-08 | 10 percent owner |
SNSS | Sunesis Pharmaceuticals Inc | 2014-08-27 | 10 percent owner |
LOXO | Loxo Oncology Inc | 2014-08-06 | 10 percent owner |
HIVE | Aerohive Networks Inc | 2014-04-02 | 10 percent owner |
WDAY | Workday Inc | 2014-02-28 | director & 10 percent owner |
ECOM | ChannelAdvisor Corp | 2013-05-22 | 10 percent owner |
CBIO | Catalyst Biosciences Inc | 2013-12-05 | 10 percent owner |
XOOM | Xoom Corp | 2013-10-29 | 10 percent owner |
GRPN | Groupon Inc | 2013-08-15 | 10 percent owner |
CLVSQ | Clovis Oncology Inc | 2011-11-21 | 10 percent owner |
MM | Millennial Media Inc | 2012-10-29 | 10 percent owner |
INWK | InnerWorkings Inc | 2012-03-28 | 10 percent owner |
FOLD | Amicus Therapeutics Inc | 2007-05-30 | 10 percent owner |
ECHO | Echo Global Logistics Inc | 2009-10-01 | 10 percent owner |
GLUU | Glu Mobile Inc | 2011-08-08 | 10 percent owner |
VG | Vonage Holdings Corp | 2006-05-23 | 10 percent owner |
ARYX | ARYx Therapeutics Inc | 2011-03-10 | 10 percent owner |
VLTC | Voltari Corp | 2010-06-23 | 10 percent owner |
WWHC | W World Corp | 2009-05-08 | 10 percent owner |
IQNT | Inteliquent Inc | 2009-02-20 | 10 percent owner |
PRTK | Paratek Pharmaceuticals Inc | 2006-05-09 | 10 percent owner |
ARDMQ | Aradigm Corp | 2003-12-31 | 10 percent owner |
VIRX | Viracta Therapeutics Inc | 2009-04-03 | 10 percent owner |
SVRA | Savara Inc | 2023-07-17 | 10 percent owner |
CVRX | CVRx Inc | 2021-06-29 | 10 percent owner |
YMTX | Yumanity Therapeutics Inc | 2016-02-10 | 10 percent owner |
UTRS | Minerva Surgical Inc | 2021-10-21 | 10 percent owner |
TPST | Tempest Therapeutics Inc | 2018-12-07 | 10 percent owner |
RPHM | Reneo Pharmaceuticals Inc | 2021-04-08 | 10 percent owner |
COUR | Coursera Inc | 2021-03-30 | director & 10 percent owner |
VRNA | Verona Pharma PLC | 2021-01-01 | 10 percent owner |
NEUE | NeueHealth Inc | 2021-06-24 | 10 percent owner |
DM | Desktop Metal Inc | 2020-12-09 | 10 percent owner |
HOOD | Robinhood Markets Inc | 2022-05-12 | director & 10 percent owner |
ACLX | Arcellx Inc | 2022-12-23 | 10 percent owner |
BGRY | Berkshire Grey Inc | 2021-07-21 | 10 percent owner |
IONQ | IonQ Inc | 2021-09-30 | 10 percent owner |
GLUE | Monte Rosa Therapeutics Inc | 2021-06-23 | 10 percent owner |
BZFD | BuzzFeed Inc | 2021-12-03 | 10 percent owner |
SNTI | Senti Biosciences Inc | 2022-06-08 | 10 percent owner |
ZFOX | ZeroFox Holdings Inc | 2022-08-03 | 10 percent owner |
KA | Kineta Inc | 2016-02-10 | 10 percent owner |
ELVN | Enliven Therapeutics Inc | 2020-03-11 | 10 percent owner |
GGNNQ | Genocea Biosciences Inc | 2018-01-19 | 10 percent owner |
SGMT | Sagimet Biosciences Inc | 2023-07-13 | 10 percent owner |
RAACU | Revolution Acceleration Acquisition Corp | 2021-07-21 | 10 percent owner |
KRRO | Korro Bio Inc | 2024-04-22 | 10 percent owner |
Scott D Sandell Latest Holdings Summary
Scott D Sandell currently owns a total of 44 stocks. Among these stocks, Scott D Sandell owns 10,420,645 shares of Tesaro Inc (TSRO) as of March 6, 2018, with a value of $781 Million and a weighting of 22.49%. Scott D Sandell owns 13,605,419 shares of iShares Indl/Office Real Estate Capped (FNIO) as of April 30, 2012, with a value of $434 Million and a weighting of 12.49%. Scott D Sandell also owns 23,850,644 shares of Robinhood Markets Inc (HOOD) as of May 12, 2022, with a value of $426 Million and a weighting of 12.28%. The other 41 stocks Arcellx Inc (ACLX) , Supernus Pharmaceuticals Inc (SUPN) , Rhythm Pharmaceuticals Inc (RYTM) , Ra Pharmaceuticals Inc (RARX) , Echo Global Logistics Inc (ECHO) , Adaptimmune Therapeutics PLC (ADAP) , Savara Inc (SVRA) , Mirum Pharmaceuticals Inc (MIRM) , Ardelyx Inc (ARDX) , Korro Bio Inc (KRRO) , Boingo Wireless Inc (WIFI) , AVEO Pharmaceuticals Inc (AVEO) , Akouos Inc (AKUS) , Groupon Inc (GRPN) , Trevi Therapeutics Inc (TRVI) , Liquidia Corp (LQDA) , Mersana Therapeutics Inc (MRSN) , Cloudflare Inc (NET) , InnerWorkings Inc (INWK) , Millennial Media Inc (MM) , Bloom Energy Corp (BE) , Inozyme Pharma Inc (INZY) , Tableau Software Inc (DATA) , Epizyme Inc (EPZM) , GlycoMimetics Inc (GLYC) , Marker Therapeutics Inc (MRKR) , Surface Oncology Inc (SURF) , Regulus Therapeutics Inc (RGLS) , Workday Inc (WDAY) , Eargo Inc (EAR) , Catalyst Biosciences Inc (CBIO) , Dermira Inc (DERM) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , Clovis Oncology Inc (CLVSQ) , TRACON Pharmaceuticals Inc (TCON) , Metacrine Inc (MTCR) , Novation Companies Inc (NOVCQ) , ARCA biopharma Inc (ABIO) , Genocea Biosciences Inc (GNCAQ) , Appian Corp (APPN) have a combined weighting of 52.73% among all his current holdings.
Latest Holdings of Scott D Sandell
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TSRO | Tesaro Inc | 2018-03-06 | 10,420,645 | 74.96 | 781,131,549 |
FNIO | iShares Indl/Office Real Estate Capped | 2012-04-30 | 13,605,419 | 31.89 | 433,876,812 |
HOOD | Robinhood Markets Inc | 2022-05-12 | 23,850,644 | 17.88 | 426,449,515 |
ACLX | Arcellx Inc | 2022-12-23 | 4,746,494 | 51.92 | 246,437,968 |
SUPN | Supernus Pharmaceuticals Inc | 2015-06-17 | 7,641,250 | 30.07 | 229,772,388 |
RYTM | Rhythm Pharmaceuticals Inc | 2017-10-10 | 4,909,956 | 38.28 | 187,953,116 |
RARX | Ra Pharmaceuticals Inc | 2016-10-31 | 3,490,073 | 47.99 | 167,488,603 |
ECHO | Echo Global Logistics Inc | 2009-10-01 | 2,420,219 | 48.24 | 116,751,365 |
ADAP | Adaptimmune Therapeutics PLC | 2020-01-24 | 102,478,668 | 1.08 | 110,164,568 |
SVRA | Savara Inc | 2023-07-17 | 24,471,264 | 4.41 | 107,918,274 |
MIRM | Mirum Pharmaceuticals Inc | 2019-07-22 | 4,186,243 | 24.46 | 102,395,504 |
ARDX | Ardelyx Inc | 2021-12-15 | 10,752,106 | 6.42 | 69,028,521 |
KRRO | Korro Bio Inc | 2024-04-22 | 1,090,793 | 62.93 | 68,643,603 |
WIFI | Boingo Wireless Inc | 2013-12-11 | 4,467,960 | 13.99 | 62,506,760 |
AVEO | AVEO Pharmaceuticals Inc | 2020-06-19 | 3,952,958 | 15.00 | 59,294,370 |
AKUS | Akouos Inc | 2020-06-30 | 4,294,207 | 13.29 | 57,070,011 |
GRPN | Groupon Inc | 2013-08-15 | 3,709,248 | 11.67 | 43,286,924 |
TRVI | Trevi Therapeutics Inc | 2022-04-11 | 11,370,376 | 2.78 | 31,609,645 |
LQDA | Liquidia Corp | 2018-07-30 | 2,484,870 | 12.53 | 31,135,421 |
MRSN | Mersana Therapeutics Inc | 2020-04-14 | 7,959,520 | 2.94 | 23,400,989 |
NET | Cloudflare Inc | 2023-11-20 | 217,859 | 88.01 | 19,173,771 |
INWK | InnerWorkings Inc | 2012-02-29 | 6,029,190 | 2.99 | 18,027,278 |
MM | Millennial Media Inc | 2012-10-29 | 8,196,614 | 1.75 | 14,344,075 |
BE | Bloom Energy Corp | 2018-07-27 | 1,333,333 | 10.60 | 14,133,330 |
INZY | Inozyme Pharma Inc | 2020-07-28 | 2,437,689 | 4.44 | 10,823,339 |
DATA | Tableau Software Inc | 2014-12-05 | 55,705 | 169.53 | 9,443,669 |
EPZM | Epizyme Inc | 2016-01-12 | 6,261,502 | 1.47 | 9,204,408 |
GLYC | GlycoMimetics Inc | 2023-01-26 | 4,967,530 | 1.64 | 8,146,749 |
MRKR | Marker Therapeutics Inc | 2021-03-16 | 1,071,429 | 4.29 | 4,596,430 |
SURF | Surface Oncology Inc | 2018-04-23 | 3,312,877 | 1.07 | 3,544,778 |
RGLS | Regulus Therapeutics Inc | 2020-12-04 | 645,106 | 2.42 | 1,561,157 |
WDAY | Workday Inc | 2014-02-28 | 5,088 | 251.04 | 1,277,292 |
EAR | Eargo Inc | 2020-10-20 | 326,001 | 2.57 | 837,823 |
CBIO | Catalyst Biosciences Inc | 2013-12-05 | 43,462 | 7.67 | 333,332 |
DERM | Dermira Inc | 2014-10-02 | 17,241 | 18.75 | 323,269 |
ILIU | Interleukin Genetics Inc | 2016-07-29 | 55,418,811 | 0.00 | 249,385 |
AKAOQ | Achaogen Inc | 2016-12-19 | 5,215,128 | 0.03 | 130,378 |
CLVSQ | Clovis Oncology Inc | 2011-11-21 | 3,419,671 | 0.02 | 51,295 |
TCON | TRACON Pharmaceuticals Inc | 2018-03-27 | 17,330 | 1.81 | 31,367 |
MTCR | Metacrine Inc | 2021-12-22 | 2,563,257 | 0.00 | 3,589 |
NOVCQ | Novation Companies Inc | 2006-05-15 | 1,225,179 | 0.00 | 123 |
ABIO | ARCA biopharma Inc | 2018-02-26 | 0 | 3.58 | 0 |
GNCAQ | Genocea Biosciences Inc | 2022-05-25 | 0 | 0.00 | 0 |
APPN | Appian Corp | 2017-11-27 | 0 | 37.56 | 0 |
Holding Weightings of Scott D Sandell
Scott D Sandell Form 4 Trading Tracker
According to the SEC Form 4 filings, Scott D Sandell has made a total of 0 transactions in Tesaro Inc (TSRO) over the past 5 years. The most-recent trade in Tesaro Inc is the acquisition of 145,532 shares on March 6, 2018, which cost Scott D Sandell around $8 Million.
According to the SEC Form 4 filings, Scott D Sandell has made a total of 0 transactions in iShares Indl/Office Real Estate Capped (FNIO) over the past 5 years. The most-recent trade in iShares Indl/Office Real Estate Capped is the sale of 20,249 shares on April 30, 2012, which brought Scott D Sandell around $535,586.
According to the SEC Form 4 filings, Scott D Sandell has made a total of 3 transactions in Robinhood Markets Inc (HOOD) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Robinhood Markets Inc is the sale of 8,792 shares on May 12, 2022, which brought Scott D Sandell around $73,941.
More details on Scott D Sandell's insider transactions can be found in the Insider Trading History of Scott D Sandell table.Insider Trading History of Scott D Sandell
- 1
Scott D Sandell Trading Performance
GuruFocus tracks the stock performance after each of Scott D Sandell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Scott D Sandell is 8.02%. GuruFocus also compares Scott D Sandell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Scott D Sandell within 3 months outperforms 32 times out of 57 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Scott D Sandell's insider trading performs compared to the benchmark.
Performance of Scott D Sandell
Average Return
-20.8%
Outperforming Transactions
24%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 6.31 | 8.02 | 5.48 | -20.8 | -31.06 | -27.49 |
Relative Return to S&P 500(%) | 5.48 | 5.13 | -1.32 | -34.93 | -41.82 | -39.91 |
Scott D Sandell Ownership Network
Ownership Network List of Scott D Sandell
Ownership Network Relation of Scott D Sandell
Scott D Sandell Owned Company Details
What does Eargo Inc do?
Who are the key executives at Eargo Inc?
Scott D Sandell is the 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .
Eargo Inc (EAR) Insider Trades Summary
Over the past 18 months, Scott D Sandell made no insider transaction in Eargo Inc (EAR). Other recent insider transactions involving Eargo Inc (EAR) include a net sale of 2,012 shares made by William Brownie , a net sale of 725 shares made by Adam Laponis , and a net sale of 92 shares made by Mark Thorpe .
In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc (EAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,799 shares of Eargo Inc (EAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,799 shares.
Eargo Inc (EAR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eargo Inc Insider Transactions
Scott D Sandell Mailing Address
Above is the net worth, insider trading, and ownership report for Scott D Sandell. Currently GuruFocus does not have mailing address information for Scott D Sandell.